SCHEMBL17016181

SCHEMBL17016181

O=C(c1ccccc1)c1cccc(-n2ccc3c2ccc2c4ccccc4n(-c4ccccc4)c23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.41
CNR2 P34972 1/20 0.40
KDM4E B2RXH2 3/20 0.40
ATM Q13315 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GLA P06280 1/20 0.39
ROCK2 O75116 1/20 0.37
PIM1 P11309 1/20 0.37
PIM3 Q86V86 1/20 0.37
FOLH1 Q04609 1/20 0.37
SETD7 Q8WTS6 1/20 0.36
EHMT2 Q96KQ7 1/20 0.36
HPGD P15428 2/20 0.36
PTPN1 P18031 1/20 0.36
PBRM1 Q86U86 1/20 0.35
SRC P12931 1/20 0.35
CA12 O43570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015225 0.95 CNR2 (0.40) RORCCNR2KDM4EATML3MBTL1
SCHEMBL17015222 0.92 L3MBTL1 (0.41) RORCCNR2KDM4EATML3MBTL1
SCHEMBL17016174 0.92 L3MBTL1 (0.41) RORCCNR2KDM4EATML3MBTL1
SCHEMBL17016175 0.91 ROCK2 (0.40) RORCCNR2KDM4EATML3MBTL1
SCHEMBL17015695 0.90 CYP19A1 (0.38) RORCCNR2KDM4EATML3MBTL1
SCHEMBL17016296 0.89 ALDH1A1 (0.42) CNR2KDM4EATML3MBTL1TDP1
SCHEMBL17015776 0.89 CNR2 (0.36) RORCCNR2KDM4EATML3MBTL1
SCHEMBL17015226 0.87 CNR2 (0.38) RORCCNR2KDM4EATML3MBTL1
SCHEMBL17016183 0.87 CNR2 (0.38) RORCCNR2KDM4EATML3MBTL1
SCHEMBL17015230 0.87 CLK1 (0.40) RORCCNR2KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 RORC 3644/4885CNR2 1583/4885KDM4E 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.